Incyte (INCY) Tops Q3 EPS by 33c; Jakafi Sales Up 63%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. META
10. TLT

Go back to Incyte (INCY) Tops Q3 EPS by 33c; Jakafi Sales Up 63%

Goldman Sachs Upgrades Incyte (INCY) to Neutral

October 31, 2014 7:20 AM EDT

Goldman Sachs upgraded Incyte (NASDAQ: INCY) from Sell to Neutral with a price target of $62.00 (from $32.00).

Analyst Navdeep Singh said, "Our Sell thesis was based on our more cautious view on Jakafis launch for myelofibrosis (MF) given safety and competition,... More